Stable Payouts Make These Three Stocks Irresistible to Income Investors

Three dividend stocks stand out as 'no-brainer' buys right now: AbbVie, Realty Income, and Procter & Gamble. These blue-chip companies have a long history of stable payouts and strong financials.

AbbVie is a pharmaceutical giant that has staged a comeback after losing patent exclusivity for its flagship drug Humira. The company's new anti-inflammatory drugs, Skyrizi and Rinvoq, have seen significant sales growth, with Skyrizi topping $5.5 billion in the last quarter. AbbVie continues to build its immunology pipeline through acquisitions, including a recent deal worth $11 billion.

With a 2.7% dividend yield and a forward payout ratio of around 42.3%, AbbVie's dividend appears well-covered. The company has raised its dividend each year since its spin-off from Abbott Laboratories in 2013, with an average growth rate of 6.8% over the past five years.

Realty Income is a real estate investment trust (REIT) that offers monthly dividends and a long track record of dividend growth. The company's forward dividend yield is around 5.5%, but investors should be aware that its leases are highly rate-sensitive, which may lead to volatility in the near term.

Procter & Gamble is a Dividend King with a 70-year history of consecutive dividend growth. The company has a 3% forward dividend yield and a forward payout ratio of around 62.5%. While its recent dividend increase was modest, management expects earnings to grow at prior high single-digit levels once macroeconomic conditions normalize.